Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 2/2013

01-04-2013 | RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Impact of Sleep as a Specific Marker of Quality of Life in Allergic Rhinitis

Authors: Vanesa González-Núñez, Antonio Luís Valero, Joaquim Mullol

Published in: Current Allergy and Asthma Reports | Issue 2/2013

Login to get access

Abstract

Allergic rhinitis (AR) is a common disorder, which represents a considerable burden both on individual patients and society. It is associated with bothersome symptoms, which may impair usual daily activities, sleep quality, and productivity. Associated with impaired sleep, quality of life is significantly impaired in AR patients. AR significantly contributes to sleep-disordered breathing through multiple mechanisms, with the greatest impact mediated through nasal obstruction. Sleep impairment is very common in AR patients and has a significant impact on disease-specific measures of general health and quality of life. The degree of sleep disturbance is directly related to the severity of the disease. Nasal congestion also demonstrates circadian rhythm and positional variability, worsening during nighttime hours and in supine position. Increased sleep disordered events lead to poor sleep with fatigue and daytime somnolence, impaired performance, productivity and social functioning, and an increased risk of associated diseases.
Literature
1.
Bousquet J, Khaltaev N, Cruz A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy. 2008;63 Suppl 86:8–160.CrossRefPubMed
2.
Meltzer EO, Blaiss MS, Derebery J, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124:S43–70.CrossRefPubMed
3.
Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758–64.CrossRefPubMed
4.
Bachert C, van Cauwenberge P, Olbrecht J, et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61:693–8.CrossRefPubMed
5.
•• Craig TJ, Sherkat A, Safaee S. Congestion and sleep impairment in allergic rhinitis. Curr Allergy Asthma Rep. 2010;10:113–21. This review examines nasal congestion and the associated sleep impairment of allergic rhinitis patients.CrossRefPubMed
6.
Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the burden of rhinitis in America survey. Allergy Asthma Proc. 2009;30:244–54.CrossRefPubMed
7.
Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) in collaboration with the World Health Organization (WHO). J Allergy Clin Immunol. 2001;108:S147–336.CrossRefPubMed
8.
Valero A, Ferrer M, Baró E, et al. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis. Allergy. 2010;65:1609–13.CrossRefPubMed
9.
Valero A, Ferrer M, Sastre J, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol. 2007;120:359–65.CrossRefPubMed
10.
Pratt EL, Craig TJ. Assessing outcomes from the sleep disturbance associated with rhinitis. Curr Opin Allergy Clin Immunol. 2007;7:249–56.CrossRefPubMed
11.
Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis. Treat Respir Med. 2005;4:439–46.CrossRefPubMed
12.
Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77–83.CrossRefPubMed
13.
Smolensky M, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95:1084–96.CrossRefPubMed
14.
Santos CB, Pratt EL, Hanks C, et al. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol. 2006;97:579–87.CrossRefPubMed
15.
Reinberg A, Gervais P, Levi F, et al. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol. 1988;81:51–62.CrossRefPubMed
16.
• Bousquet J, Neukirch F, Bousquet PJ, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol. 2006;117:158–62. In this study, performed in general practice on a large number of patients with allergic rhinitis, the severity of the rhinitis was having more effect on QOL, sleep, daily activities, and work performance than in the duration.CrossRefPubMed
17.
Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. Am J Respir Crit Care Med. 2000;162:1391–6.PubMed
18.
Juniper EF, Thompson AK, Ferrie PJ, et al. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104:364–9.CrossRefPubMed
19.
Baiardini I, Braido F, Brandi S, et al. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol. 2006;97:419–29.CrossRefPubMed
20.
Juniper EF, Guyatt GH, Andersson B, et al. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy. 1993;70:225–30.PubMed
21.
Juniper EF, Thompson AK, Ferrie PJ, et al. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy. 2000;30:132–40.CrossRefPubMed
22.
Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2003;111:484–90.CrossRefPubMed
23.
Santilli J, Nathan R, Glassheim J, et al. Validation of the rhinitis outcomes questionnaire (ROQ). Ann Allergy Asthma Immunol. 2001;86:222–5.CrossRefPubMed
24.
Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy. 2003;58:289–94.CrossRefPubMed
25.
Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163–70.CrossRefPubMed
26.
Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750–6.CrossRefPubMed
27.
Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immnol. 1994;94:182–8.CrossRef
28.
Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol. 1997;99:S742–9.CrossRefPubMed
29.
ESPRINT study group. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The Esprint Questionnaire. Val Health. 2007;10(6):466–77.CrossRef
30.
Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy. 2002;32:1310–5.CrossRefPubMed
31.
32.
Kremer B. Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:171–6.CrossRefPubMed
33.
Miraglia Del Giudice M, Marseglia A, Leonardi S, et al. Allergic rhinitis and quality of life in children. Int J Immunopathol Pharmacol. 2011;24(S):25–8.PubMed
34.
van Oene CM, van Reij JF, Sprangers MAG, et al. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007;62:1359–71.CrossRefPubMed
35.
Stuck BA, Czajkowski J, Hagner A, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113:663–8.CrossRefPubMed
36.
•• Colás C, Galera H, Añibarro B, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42:1080–7. This study shows that sleep quality is altered in AR patients, and that a greater severity of AR is correlated with a poorer sleep quality.CrossRefPubMed
37.
Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994;93:413–23.CrossRefPubMed
38.
Valero A, Alonso J, Antépara I, et al. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62(12):1372–8.CrossRefPubMed
39.
Valero A, Baró E, Sastre J, et al. Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version). J Investig Allergol Clin Immunol. 2009;19(5):396–403.PubMed
40.
Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy. 1993;71(2):121–6.PubMed
41.
Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep. Arch Intern Med. 2006;166:1744–8.CrossRefPubMed
42.
Soose RJ. Role of allergy in sleep-disordered breathing. Otolaryngol Clin N Am. 2011;44:625–35.CrossRef
43.
Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431–6.CrossRefPubMed
44.
Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J ClinEpidemiol. 1988;41:313–21.CrossRef
45.
Lallukka T, Dregan A, Armstrong D. Comparison of a sleep item from the General Health Questionnaire-12 with the Jenkins Sleep Questionnaire as measures of sleep disturbance. J Epidemiol. 2011;21:474–80.CrossRefPubMed
46.
Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed
47.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540–5.PubMed
48.
Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835–43.PubMed
49.
Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6:41–4.CrossRefPubMed
50.
Chervin RD, Hedger K, Dillon JE, et al. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000;1:21–31.CrossRefPubMed
51.
• Ishman SL, Smith DF, Benke JR, et al. The prevalence of sleepiness and the risk of sleep-disordered breathing in children testing positive for allergy. Int Forum Allergy Rhinol. 2012;2:139–43. This study suggests that children with AR are at increased risk for sleep-disordered breathing.CrossRefPubMed
52.
Drake C, Nickel C, Rothe T, et al. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcome in middle-school children. Sleep. 2003;26:455–8.PubMed
53.
Baiardini I, Braido F, Cauglia S, et al. Sleep disturbances in allergic diseases. Allergy. 2006;61:1259–67.CrossRefPubMed
54.
• Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011;29:297–306. This review examines nasal congestion and the associated sleep impairment in allergic rhinitis.PubMed
55.
Gurevich F, Glass C, Davies M, et al. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2005;26:268–74.PubMed
56.
Lavie P, Gertner R, Zomer J, et al. Breathing disorders in sleep associated with “microarousals” in patients with allergic rhinitis. Acta Otolaryngol. 1981;92:529–33.CrossRefPubMed
57.
Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S757–62.CrossRefPubMed
58.
Craig TJ, Teets S, Lehman E, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101:633–7.CrossRefPubMed
59.
Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161:1514–9.CrossRefPubMed
60.
Krouse HJ, Davis JE, Krouse JH. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002;126:607–13.CrossRefPubMed
61.
Craig TJ, Mende C, Hughes K, et al. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24:53–8.PubMed
62.
Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58:380–5.CrossRefPubMed
63.
Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30:358–65.CrossRefPubMed
64.
Stull DE, Schaefer M, Crespi S, et al. Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity. Curr Med Res Opin. 2009;25:1785–92.CrossRefPubMed
65.
Yuksel H, Sogut A, Yilmaz H, et al. Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2009;103:290–4.CrossRefPubMed
66.
Meltzer EO, Munafo DA, Chung W, et al. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol. 2010;105:65–74.CrossRefPubMed
67.
Meng J, Xuan J, Qiao X, et al. Assessment of sleep impairment in persistent allergic rhinitis patients using polysomnography. Int Arch Allergy Immunol. 2011;155:57–62.CrossRefPubMed
68.
Sherkat AA, Sardana N, Safaee S, et al. The role of pseudoephedrine on daytime somnolence in patients suffering from perennial allergic rhinitis (PAR). Ann Allergy Asthma Immunol. 2011;106:97–102.CrossRefPubMed
69.
Yamada T, Yamamoto H, Kubo S, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2012;33:e9–e16.CrossRefPubMed
70.
Chivato T, Valovirta E, Dahl R, et al. Allergy, living and learning: diagnosis and treatment of allergic respiratory diseases in Europe. J Investig Allergol Clin Immunol. 2012;22:168–79.PubMed
71.
Blaiss M, Reigel T, Philpot E. A study to determine the impact of rhinitis on sufferers’ sleep and daily routine [abstract 787]. J Allergy Clin Immunol. 2005;115:S197.CrossRef
72.
Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Respir Med. 2002;1(3):195–200.CrossRefPubMed
73.
McNicholas WT, Tarlo S, Cole P, et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126:625–8.PubMed
74.
Rappai M, Collop N, Kemp S, et al. The nose and sleep-disordered breathing. What we do not know. Chest. 2003;124:2309–23.CrossRefPubMed
75.
Modrzynski M, Zawisza E. An analysis of the incidence of adenoid hypertrophy in allergic children. Int J Pediatr Otorhinolaryngol. 2007;71:713–9.CrossRefPubMed
76.
Craig TJ, Ferguson BJ, Krouse JH. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol. 2008;29:209–17.CrossRefPubMed
77.
Zwillich CW, Picket C, Hanson FN, et al. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis. 1981;124(2):158–60.PubMed
78.
Anuntaseree W, Rookkapan K, Kuasirikul S, et al. Snoring and obstructive sleep apnea in Thai scool-age children: prevalence and predisposing factors. Pediatr Pulmonol. 2001;32:222–7.CrossRefPubMed
79.
Chng SY, Goh DY, Wang XS, et al. Snoring and atopic disease: a strong association. Pediatr Pulmonol. 2004;38:210–6.CrossRefPubMed
80.
Kalra M, Lemasters G, Bernstein D, et al. Atopy as a risk factor for habitual snoring at age 1 year. Chest. 2006;129:942–6.CrossRefPubMed
81.
McCollley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest. 1997;111:170–3.CrossRef
82.
Mullol J, Maurer M, Bousquet J. Sleep and allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18:415–9.
83.
Craig TJ, Hanks CD, Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis? J Allergy Clin Immunol. 2005;116:1264–6.CrossRefPubMed
84.
Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review or randomized controlled trials. BMJ. 1998;317:1624–9.CrossRefPubMed
85.
Bender BG, Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92:344–9.CrossRefPubMed
86.
Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010. J Allergy Clin Immunol. 2010;126:466–7.CrossRefPubMed
87.
Potter PC, Van Niekerk CH, Schoeman HS. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:368–74.CrossRefPubMed
88.
Mintz M, Garcia J, Diener P, et al. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92:255–61.CrossRefPubMed
89.
Mansfield LE, Posey CR. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc. 2007;28:226–9.CrossRefPubMed
90.
Valero A, Izquierdo I, Giralt J, et al. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. J Investig Allergol Clin Immunol. 2011;21(3):229–35.PubMed
91.
Katayose Y, Aritake S, Kitamura S, et al. Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial. Hum Psychopharmacol Clin Exp. 2012;27:428–36.CrossRef
92.
Milgrom H, Biondi R, Georgitis JW, et al. Comparison of ipratropium bromide 0.03 % with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999;83:105–11.CrossRefPubMed
93.
Cingi C, Ozlugedik S. Effects of montelukast on quality of life in patients with persistent allergic rhinitis. Otolaryngol Head Neck Surgery. 2010;142:654–8.CrossRef
94.
Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105:917–22.CrossRefPubMed
95.
Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130:617–29.CrossRefPubMed
96.
Jáuregui I, Mullol J, Bartra J, et al. H1 antihistamines: psychomotor performance and driving. J Investig Allergol Clin Immunol. 2006;16:S37–44.
97.
Montoro J, Mullol J, Dávila I, et al. Bilastine and the central nervous system. J Investig Allergol Clin Immunol. 2011;S3:9–15.
98.
Fang BJ, Tonelli LH, Soriano JJ, et al. Disturbed sleep: linking allergic rhinitis, mood and suicidal behavior. Front Biosci. 2010;2:30–46.CrossRef
99.
Smolensky M, di Milia L, Ohayon MM, et al. Sleep disorders, medical conditions, and road accident risk. Accid Anal Prev. 2011;43:533–48.CrossRefPubMed
Metadata
Title
Impact of Sleep as a Specific Marker of Quality of Life in Allergic Rhinitis
Authors
Vanesa González-Núñez
Antonio Luís Valero
Joaquim Mullol
Publication date
01-04-2013
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 2/2013
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-012-0330-z

Other articles of this Issue 2/2013

Current Allergy and Asthma Reports 2/2013 Go to the issue

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

The Role of Interleukin-33 in Rhinitis

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Fungal Disease of the Nose and Sinuses: An Updated Overview

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Gene Expression Signatures: A New Approach to Understanding the Pathophysiology of Chronic Rhinosinusitis

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Disease-Specific Quality-of-Life Questionnaires in Rhinitis and Rhinosinusitis: Review and Evaluation

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Role of Fungi in the Pathophysiology of Chronic Rhinosinusitis: An Update

SINUSITIS (ML KOWALSKI, SECTION EDITOR)

Gastroesophageal Reflux and Rhinosinusitis